Bristol Myers Squibb Subsidiaries & Acquisitions

  • October 23, 2024

Bristol Myers Squibb has expanded its reach into new industries through a series of key acquisitions. By acquiring companies in healthcare, renewable energy, and technology, it has strengthened its market position and broadened its range of products. These moves have helped Bristol stay competitive and better serve its customers’ needs, while ensuring continued growth and innovation in multiple sectors.

Notable Acquisitions of Bristol Myers Squibb

  1. Celgene (2019) – Oncology and Immunology: Focused on treatments for cancer and immune-inflammatory diseases.
  2. MyoKardia (2020) – Cardiovascular Disease: Specializes in therapies for cardiovascular disorders, particularly heart muscle diseases.
  3. Forbius (2020) – Immuno-Oncology: Engaged in the development of cancer and fibrotic disease therapies.
  4. IFM Therapeutics (2017) – Immunology: Concentrates on immune system regulation and treatment of inflammation-related diseases.
  5. Padlock Therapeutics (2016) – Autoimmune Diseases: Develops therapies targeting autoimmune disorders, particularly rheumatoid arthritis.
  6. Cardioxyl Pharmaceuticals (2015) – Cardiovascular: Focuses on treatments for acute decompensated heart failure and other heart conditions.
  7. Amylin Pharmaceuticals (2012) – Diabetes: Specializes in diabetes and metabolic disease treatments.
  8. ZymoGenetics (2010) – Biologics: Develops protein therapeutics for immune modulation, viral diseases, and tissue repair.
  9. Medarex (2009) – Immuno-Oncology: Known for developing monoclonal antibody therapies, particularly in cancer treatment.
  10. DuPont Pharmaceuticals (2001) – Cardiovascular and Infectious Diseases: Focused on therapeutic areas including cardiovascular, HIV, and central nervous system disorders.

List of Bristol Myers Squibb Acquisitions

S. NoAcquiree NameAnnounced DatePrice
1RayzeBioDec 26, 2023—
2Karuna TherapeuticsDec 22, 2023$14B
3Mirati TherapeuticsOct 08, 2023$4.8B
4Turning Point TherapeuticsJun 03, 2022$4.1B
5MyoKardiaOct 05, 2020$13.1B
6ForbiusAug 24, 2020—
7CelgeneNov 20, 2019$74B
8IFM TherapeuticsAug 03, 2017—
9Cormorant PharmaceuticalsJul 05, 2016—
10Padlock TherapeuticsMar 23, 2016$600M
11Cardioxyl PharmaceuticalsNov 02, 2015$2B
12Flexus BiosciencesFeb 23, 2015$1.3B
13iPierianApr 29, 2014$725M
14Amylin PharmaceuticalsJul 01, 2012$5.3B
15InhibitexJan 07, 2012$2.5B
16Amira PharmaceuticalsJul 21, 2011$475M
17ZymoGeneticsSep 08, 2010$885M
18MedarexJul 22, 2009—
19ConvaTec DivestitureAug 01, 2008—
20Kosan BiosciencesMay 28, 2008$190M
21AdnexusSep 24, 2007$415M
22DuPont PharmaceuticalsOct 02, 2001—

List of Bristol Myers Squibb Subsidiaries

The table contains the 100 subsidiaries of Bristol Myers Squibb –

S. NoCompanyCountry
1345 Park LlcUnited States
2Abraxis Bioscience IncUnited States
3Abraxis Bioscience International Holding Company IncUnited States
4Abraxis Bioscience LlcUnited States
5Abraxis Bioscience Puerto Rico LlcUnited States
6Abvitro LlcUnited States
7Acetylon Pharmaceuticals IncUnited States
8Adnexus A Bristol-Myers Squibb R&D CompanyUnited States
9Ahi Investment LlcUnited States
10Allard Labs Acquisition GpUnited States
11Amira Pharmaceuticals IncUnited States
12Apothecon LlcUnited States
13Blisa Acquisition GpUnited States
14Bms Bermuda Nominees LlcUnited States
15Bms Forex CompanyUnited States
16Bms Korea Holdings LlcUnited States
17Bms Latin American Nominees LlcUnited States
18Bms Real Estate LlcUnited States
19Bms Spain Investments LlcUnited States
20Bms Strategic Portfolio Investments Holdings IncUnited States
21Bristol Laboratories International SaUnited States
22Bristol Laboratories Medical Information Systems IncUnited States
23Bristol-Myers (Andes) LlcUnited States
24Bristol-Myers Overseas CorporationUnited States
25Bristol-Myers Squibb (West Indies) LtdUnited States
26Bristol-Myers Squibb De Colombia SaUnited States
27Bristol-Myers Squibb De Costa Rica Sociedad AnonimaUnited States
28Bristol-Myers Squibb De Guatemala SaUnited States
29Bristol-Myers Squibb Ilaclari IncUnited States
30Bristol-Myers Squibb International CorporationUnited States
31Bristol-Myers Squibb Investco LlcUnited States
32Bristol-Myers Squibb Norway Holdings IncUnited States
33Bristol-Myers Squibb Pharma CompanyUnited States
34Bristol-Myers Squibb Pharma Holding Company LlcUnited States
35Bristol-Myers Squibb Pharma Ventures CorporationUnited States
36Bristol-Myers Squibb Puerto Rico IncUnited States
37Cardioxyl Pharmaceuticals LlcUnited States
38Celgene Car LlcUnited States
39Celgene China Holdings LlcUnited States
40Celgene CorporationUnited States
41Celgene Financing Company LlcUnited States
42Celgene Holdings East CorporationUnited States
43Celgene International Holdings CorporationUnited States
44Celgene International IncUnited States
45Celgene Kappa Holdings LlcUnited States
46Celgene Nj Investment CoUnited States
47Celgene Omicron Holdings IncUnited States
48Celgene Puerto Rico Distribution LlcUnited States
49Celgene Quanticel Research IncUnited States
50Celgene Research And Investment Company Ii LlcUnited States
51Celgene Research Incubator At Summit West LlcUnited States
52Celgene Rivot Beta Holdings LlcUnited States
53Celgene Rivot SrlUnited States
54Celgene Summit Investment CoUnited States
55Celgene Switzerland LlcUnited States
56Cht I LlcUnited States
57Delinia LlcUnited States
58Deuteria Pharmaceuticals IncUnited States
59E R Squibb & Sons Inter-American CorporationUnited States
60E R Squibb & Sons LlcUnited States
61Fermavir Pharmaceuticals LlcUnited States
62Fermavir Research LlcUnited States
63Flexus Biosciences IncUnited States
64Genpharm International LlcUnited States
65Gloucester Pharmaceuticals LlcUnited States
66Impact Biomedicines IncUnited States
67Inhibitex LlcUnited States
68Innate Tumor Immunity IncUnited States
69Ipierian IncUnited States
70Jump Holdings LlcUnited States
71Juno Therapeutics IncUnited States
72Kosan Biosciences IncorporatedUnited States
73Linson Investments LimitedUnited States
74Mead Johnson Jamaica LtdUnited States
75Morris Avenue Investment Ii LlcUnited States
76Morris Avenue Investment LlcUnited States
77Myokardia IncUnited States
78Padlock Therapeutics IncUnited States
79Pharmion LlcUnited States
80Princeton Pharmaceutical Products IncUnited States
81Receptos Holdings LlcUnited States
82Receptos LlcUnited States
83Receptos Services LlcUnited States
84Redoxtherapies IncUnited States
85Signal Pharmaceuticals LlcUnited States
86Squibb Middle East SaUnited States
87Summit West Celgene LlcUnited States
88Turning Point Therapeutics IncUnited States
89Ventirx Pharmaceuticals IncUnited States
90Westwood-Squibb Pharmaceuticals IncUnited States
91X-Body IncUnited States
92Zymogenetics IncUnited States
93Linson Investments LimitedUnited States
94Zymogenetics Paymaster LlcUnited States
95Bristol-Myers Squibb (China) Investment Co LtdChina
96Bristol-Myers Squibb (China) Pharmaceuticals Co LtdChina
97Bristol-Myers Squibb (Shanghai) Trading Co LtdChina
98Bristol-Myers Squibb (Taiwan) LtdChina
99Celgene LimitedChina
100Celgene Pharmaceutical (Shanghai) Company LimitedChina

Table of Content

Insights you may find interesting

Related Articles

American Financial Group Subsidiaries & Acquisitions

American Financial Group (AFG) has strategically expanded its presence across various industries through targeted acquisitions and subsidiaries. By integrating businesses in specialty insurance, reinsurance, and financial services, AFG has solidified its role as a diversified financial leader, offering tailored solutions and driving growth to meet evolving customer needs. How many

Read More »

Vinci Subsidiaries & Acquisitions

Vinci has broadened its reach through acquisitions in construction, energy, and transportation, enhancing its market position and innovation capacity. These moves, particularly in renewable energy and smart mobility, support sustainable growth and urban development, reinforcing Vinci’s leadership across industries. Notable Acquisitions of Vinci List of Vinci Acquisitions S. No. Acquiree

Read More »

Infosys Subsidiaries & Acquisitions

Infosys, a global IT services leader, has grown its presence across industries through targeted acquisitions and subsidiaries. By acquiring companies in cloud computing, digital services, cybersecurity, and engineering, Infosys has expanded its expertise and adapted to changing client demands. These strategic moves have strengthened its market position and service offerings,

Read More »
Topics:

Was this article helpful?

Yes No

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.